|
OMIM |
Link |
Information gain |
01 |
|
PCOS1
|
[NCBI]
|
0.00181128
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
0.000767726
|
|
|
SHBG
|
[NCBI]
|
0.000234975
|
|
|
adrenal hyperplasia, congenital, due to steroid 11-beta-hydroxylase deficiency
|
[NCBI]
|
0.000224389
|
|
|
lipoid congenital adrenal hyperplasia
|
[NCBI]
|
0.000101568
|
|
|
17-@beta hydroxysteroid dehydrogenase iii deficiency
|
[NCBI]
|
0.000101568
|
|
|
ABS
|
[NCBI]
|
0.000101568
|
|
|
adrenal hyperplasia, congenital, due to 17-alpha-hydroxylase deficiency
|
[NCBI]
|
9.63599e-05
|
|
|
PRL
|
[NCBI]
|
5.37584e-05
|
|
|
RA
|
[NCBI]
|
5.06489e-05
|
|
|
BWS
|
[NCBI]
|
5.01602e-05
|
|
|
AIS
|
[NCBI]
|
4.94604e-05
|
|
|
SLOS
|
[NCBI]
|
4.74919e-05
|
|
|
ALD
|
[NCBI]
|
3.70521e-05
|
|
|
temporal arteritis
|
[NCBI]
|
3.54098e-05
|
|
|
SERPINA6
|
[NCBI]
|
2.26176e-05
|
|
|
CYP11A1
|
[NCBI]
|
2.25469e-05
|
|
|
AMH
|
[NCBI]
|
2.24819e-05
|
|
|
3-@beta-hydroxysteroid dehydrogenase, type ii, deficiency of
|
[NCBI]
|
2.1451e-05
|
|
|
CYP17A1
|
[NCBI]
|
1.71394e-05
|
|
|
AR
|
[NCBI]
|
1.63125e-05
|
|
|
CYP19A1
|
[NCBI]
|
1.53239e-05
|
|
|
CRH
|
[NCBI]
|
1.16734e-05
|
|
|
GNRH1
|
[NCBI]
|
1.03138e-05
|
|
|
EGF
|
[NCBI]
|
7.05472e-06
|
|
|
STAR
|
[NCBI]
|
6.98556e-06
|
|
|
CP
|
[NCBI]
|
6.25075e-06
|
|
|
PGR
|
[NCBI]
|
5.60968e-06
|
|
|
GIP
|
[NCBI]
|
5.0105e-06
|
|
|
POMC
|
[NCBI]
|
3.03853e-06
|
|
|
SLE
|
[NCBI]
|
1.89469e-06
|
|
|
KLK3
|
[NCBI]
|
8.69667e-07
|
|
|
CFTR
|
[NCBI]
|
5.05255e-07
|
|
|
VEGF
|
[NCBI]
|
3.9418e-07
|
|
|
CAT
|
[NCBI]
|
2.89743e-07
|
|
|
TNF
|
[NCBI]
|
2.14767e-07
|
|
|
VIP
|
[NCBI]
|
2.10395e-08
|
|